Farmax India Peer Comparison

NSE: FARMAXIND | BSE: 590094

₹0.05

₹0.00 (0.00%)

As on 02-Jul-2018IST

Market cap

₹5 Cr

Revenue (TTM)

₹4 Cr

P/E Ratio

--

P/B Ratio

-0.3

Div. Yield

0 %

Edit

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Market cap (₹ Cr)	5	16,730	17,226	7,091	6,630
Revenue (₹ Cr)	4	4,537	3,915	2,966	1,240
Net Profit (₹ Cr)	-2.76	188.20	753.50	284.04	223.00
Net Margin (%)	-62.40	4.14	18.85	9.37	17.60
RoE (%)	--	3.99	25.89	18.77	31.86
Price to Earnings	--	88.90	23.02	24.96	29.73
Price-To-Book	-0.26	2.81	5.62	4.34	8.04

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Operating Revenue	4.38	430.57	2,488.17	1,682.99	796.55
Total Income	4.43	463.21	2,577.09	1,693.67	838.85
Total Expenditure	5.87	331.50	1,786.88	1,428.50	535.87
EBITDA	-1.49	99.07	701.28	254.49	260.69
Depreciation	1.32	7.16	308.58	30.06	5.32
EBIT	-2.80	91.91	392.71	224.43	255.37
Interest	0.00	0.55	58.01	56.47	1.03
Other Income	0.04	32.64	88.93	10.68	42.30
Exceptional Items	--	--	--	--	-18.38
Profit before Tax	-2.76	124.00	423.62	178.65	278.25
Provision for Tax	--	12.72	83.62	-25.50	60.01
Profit after Tax	-2.76	111.28	340.01	204.15	218.24

Liabilities (₹ Cr)

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Shareholder's Funds	-11.73	557.19	1,754.69	1,089.01	494.19
Minority Interest	--	10.55	1.41	-6.65	--
Non-Current Liabilities	0.73	-55.03	64.87	59.65	0.77
Current Liabilities	41.67	113.46	782.19	773.56	94.73
Total Liabilities	30.67	682.49	2,603.16	2,027.08	589.69

Assets (₹ Cr)

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Non-Current Assets	22.41	109.95	2,162.24	1,403.15	163.78
Current Assets	8.26	516.22	440.92	511.74	425.91
Total Assets	30.67	682.49	2,603.16	2,027.08	589.69
Total Debt*	41.00	25.00	472.96	498.26	15.00
Net Current Assets	-33.41	402.76	-341.27	-261.82	331.17
Contingent Liabilities	--	26.81	16.24	109.89	--

Cashflow (₹ Cr)

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Cash From Operating Activities	--	76.95	729.63	163.32	211.99
Cash Flow from Investing Activities	--	-72.05	-297.48	-17.05	-15.23
Cash from Financing Activities	--	-6.21	-495.82	-129.84	-199.98
Net Cash Inflow / Outflow	--	-1.31	-63.67	16.44	-3.21

Ratios

Profitability Ratios

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
ROCE (%)	-11.69	23.48	21.36	16.00	55.84
ROE (%)	0.00	21.49	20.20	21.32	44.76
ROA (%)	-8.56	18.64	12.84	10.68	37.76
EBIT Margin (%)	-32.93	30.59	31.76	15.76	38.04
Net Margin (%)	-62.40	24.02	13.19	12.05	26.02
Cash Profit Margin (%)	-32.95	25.61	25.66	13.39	28.05

Growth Ratios

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Revenue Growth (%)	-73.29	8.54	5.50	5.67	-0.40
EBIT Growth (%)	82.36	6.43	7.99	12.20	0.20
Net Profit Growth (%)	71.77	5.74	-6.35	176.56	11.10
EPS Growth (%)	71.76	5.54	-6.36	165.74	11.10
Book Value Growth (%)	-17.26	16.43	8.88	22.67	2.73

Valuation Ratios

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Price / Earnings	0.00	31.17	35.17	15.60	26.67
Price / Book Value	-0.26	6.10	13.65	6.15	11.78
Dividend Yield (%)	0.00	0.75	0.66	1.68	2.91
EV/EBITDA	-31.73	22.63	30.83	25.97	19.22
Market Cap (₹ Cr)	4.81	3,396.34	23,942.85	6,491.63	5,820.35

Solvency Ratios

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Debt to Equity	-2.19	0.04	0.27	0.47	0.03
Short term debt to equity ratio	-3.43	0.04	0.10	0.05	0.03
Current Ratio	0.20	4.55	0.56	0.66	4.50
Quick Ratio	0.19	4.27	0.33	0.41	4.05
Interest Coverage	-3,067.22	226.45	8.30	4.16	270.36

Operating Efficiency Ratios

	Farmax India	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Debtors to sales (%)	142.64	0.94	3.90	6.96	3.44
Asset Turnover	0.14	0.77	0.95	0.92	1.38
Receivable days	518.25	2.68	16.45	22.04	12.09
Inventory Days	88.24	22.05	23.80	39.80	21.22
Payable days	88.67	257.37	100.00	63.30	56.81
Cash Conversion Cycle	517.82	-232.64	-59.74	-1.46	-23.50